EFFECT OF BRETYLIUM ON NEUROMUSCULAR TRANSMISSIONWELCH GW; WAUD BE.1982; ANESTH. ANALG. (CLEVE.); ISSN 0003-2999; USA; DA. 1982; VOL. 61; NO 5; PP. 442-444; BIBL. 8 REF.Article

SERIAL ELECTROPHYSIOLOGIC EFFECTS OF BRETYLIUM IN MAN AND THEIR CORRELATION WITH PLASMA CONCENTRATIONSANDERSON JL; BRODINE WN; PATTERSON E et al.1982; JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; ISSN 0160-2446; USA; DA. 1982; VOL. 4; NO 6; PP. 871-882; BIBL. 46 REF.Article

Ion-selective electrodes for the determination of the antiarrhthymic drug bretyliumEPPELSHEIM, C; BRÄUCHLE, C; HAMPP, N et al.Analyst (London. 1877. Print). 1992, Vol 117, Num 10, pp 1609-1612, issn 0003-2654Article

Clinical pharmacokinetics of bretyliumRAPEPORT, W. G.Clinical pharmacokinetics. 1985, Vol 10, Num 3, pp 248-256, issn 0312-5963Article

SEVERE HYPOTENSION DUE TO THE USE OF BRETYLIUM FOR POSTCARDIOTOMY VENTRICULAR ARRHYTHMIASKRON IL; NOLAN SP.1983; ANNALS OF THORACIC SURGERY; ISSN 0003-4975; USA; DA. 1983; VOL. 35; NO 3; PP. 271-273; BIBL. 18 REF.Article

Competitive inhibition of acetylcholinesterase by Bretylium: possible mechanism for its induction of norepinephrine releaseSCHREIBER, G; SOKOLOVSKY, M.Journal of cardiovascular pharmacology. 1985, Vol 7, Num 6, pp 1065-1068, issn 0160-2446Article

Advances in drug therapy of cardiopulmonary arrestRAEHL, C. L.Clinical pharmacy. 1987, Vol 6, Num 2, pp 118-139, issn 0278-2677Article

Bretylium-induced voltage-gated sodium current in human lymphocytesGASPAR, R. JR; KRAZZNAI, Z; MARIAN, T et al.Biochimica et biophysica acta. Molecular cell research. 1992, Vol 1137, Num 2, pp 143-147, issn 0167-4889Article

Effets vasculaires régionaux d'une diminution d'activité adrénergique dans des conditions d'état calme des anumaux et dans des conditions d'immobilisationKOVALEV, O. A; PARFENOVA, M. A.Fiziologičeskij žurnal SSSR im. I.M. Sečenova. 1988, Vol 74, Num 4, pp 510-516, issn 0015-329XArticle

Poisoning by antidysrhythmic drugsMOFENSON, H. C; CARACCIO, I. R; SCHAUBEN, J et al.The Pediatric clinics of North America. 1986, Vol 33, Num 3, pp 723-738, issn 0031-3955Article

Bretylium tosylate for ventricular fibrillation in a childCHALERMLARP MONGKOLSMAI; DOVE, J. T; KYROUAC, J. T et al.Clinical pediatrics. 1984, Vol 23, Num 12, pp 696-698, issn 0009-9228Article

Interaction of bretylium tosylate with rat cardiac muscarinic receptors: possible pharmacological relevance to antiarrhythmic actionSCHREIBER, G; FRIEDMAN, M; SOKOLOVSKY, M et al.Circulation research. 1984, Vol 55, Num 5, pp 653-659, issn 0009-7330Article

Class III antiarrhythmics in overdose : presenting features and management principlesLEATHAM, E. W; HOLT, D. W; MCKENNA, W. J et al.Drug safety. 1993, Vol 9, Num 6, pp 450-462, issn 0114-5916Article

A sodium channel opener inhibits stimulation of human peripheral blood mononuclear cellsPIERI, C; RECCHIONI, R; MORONI, F et al.Molecular immunology. 1992, Vol 29, Num 4, pp 517-524, issn 0161-5890Article

Nomogram for bretylium dosing in renal impairmentADIR, J; NARANG, P. K; JOSSELSON, J et al.Therapeutic drug monitoring. 1985, Vol 7, Num 3, pp 265-268, issn 0163-4356Article

TREATMENT OF REFRACTORY VENTRICULAR ARRHYTHMIAS: HIGH DOSE PARENTERAL AND ORAL BRETYLIUM TOSYLATENONEMAN JW; BATENHORST RL; JONES MR et al.1982; CHEST; ISSN 0012-3692; USA; DA. 1982; VOL. 81; NO 4; PP. 517-519; BIBL. 3 REF.Article

FAILURE OF BRETYLIUM TO SUPPRESS INDUCIBLE VENTRICULARE TACHYCARDIAGREENE HL; WERNER JA; GROSS BW et al.1983; AMERICAN HEART JOURNAL; ISSN 0002-8703; USA; DA. 1983; VOL. 105; NO 5; PP. 717-721; BIBL. 13 REF.Article

POSTMYOCARDIAL INFARCTION RE-ENTRANT VENTRICULAR ARRHYTHMIAS IN CONSCIOUS DOGS: SUPPRESSION BY BRETYLIUM TOSYLATEPATTERSON E; GIBSON JK; LUCCHESI BR et al.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 216; NO 3; PP. 453-458; BIBL. 41 REF.Article

MECHANISM OF ACTION OF HISTAMINE IN THE ESTROGEN-PRIMED RAT UTERUSGOYAL RK; VERMA SC.1982; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1982; VOL. 77; NO 4-5; PP. 237-242; BIBL. 31 REF.Article

PHARMACOKINETICS OF BRETYLIUM IN DOGS AND THE EFFECT OF HEMOPERFUSION ON ELIMINATIONKAMATH BL; GIBSON TB; LOOK ZM et al.1982; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 11; PP. 1294-1296; BIBL. 16 REF.Article

COMPARATIVE STUDIES OF (-)-, ( +OU- ), (+)-PROPRANOLOL, ATENOLOL, GUANETHIDINE, BRETYLIUM AND TETRACAINE ON ADRENERGIC TRANSMISSIONKAIHO M; KUBO T; MISU Y et al.1981; BR. J. PHARMACOL.; ISSN 0007-1188; GBR; DA. 1981; VOL. 74; NO 2; PP. 365-370; BIBL. 33 REF.Article

BRETYLIUM TOSYLATE INTRAVENOUS ADMIXTURE COMPTABILITY II: DOPAMINE, LIDOCAINE, PROCAINAMIDE, AND NITROGLYCERINYING CHI LEE; MALICK AW; AMANN AH et al.1981; AMER. J. HOSP. PHARM.; USA; DA. 1981; VOL. 38; NO 2; PP. 183-187; BIBL. 10 REF.Article

Bretylium differentiates between distinct signal transducing pathways in human lymphocytesPIERI, C; BACSO, Z; RECCHIONI, R et al.Biochemical and biophysical research communications (Print). 1993, Vol 190, Num 2, pp 654-659, issn 0006-291XArticle

Ion pair approach of bretyliumNEUBERT, R; AMLACHTER, R; HÄRTL, A et al.Pharmazeutische Industrie. 1992, Vol 54, Num 4, pp 370-372, issn 0031-711XArticle

Bretylium tosylate binds preferentially to muscarinic receptors labelled with [³H]oxotremorine M (SH or high affinity receptors) in rat heart and brain cortexGILLARD, M; BRUNNER, F; WAELBROECK, M et al.European journal of pharmacology. 1989, Vol 160, Num 1, pp 117-124, issn 0014-2999Article